Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment—A review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alder, 2010, Fate of β-blocker human pharmaceuticals in surface water: comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland, Water Res, 44, 936, 10.1016/j.watres.2009.10.002
Alexy, 2006, Local use of antibiotics and their input and fate in a small sewage treatment plant—significance of balancing and analysis on a local scale vs. nationwide scale, Acta Hydroch Hydrob, 34, 587, 10.1002/aheh.200400657
Andersen, 2003, Fate of estrogens in a municipal sewage treatment plant, Environ Sci Technol, 37, 4021, 10.1021/es026192a
Andreozzi, 2003, Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment, Chemosphere, 50, 1319, 10.1016/S0045-6535(02)00769-5
Ashton, 2004, Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom, Sci Total Environ, 333, 167, 10.1016/j.scitotenv.2004.04.062
Batt, 2006, Enhanced biodegradation of iopromide and trimethoprim in nitrifying activated sludge, Environ Sci Technol, 40, 7367, 10.1021/es060835v
Baronti, 2000, Monitoring natural and synthetic estrogens and activated sludge sewage treatment plants and in a receiving river water, Environ Sci Technol, 34, 5059, 10.1021/es001359q
Baumgarten, 2007, Evaluation of advanced treatment technologies for the elimination of pharmaceutical compounds, Water Sci Technol, 56, 1, 10.2166/wst.2007.550
Bendz, 2005, Occurrence and fate of pharmaceutically active compounds in the environment, case study: Hoje River in Sweden, J Hazard Mater, 122, 195, 10.1016/j.jhazmat.2005.03.012
Bernhard, 2006, Biodegradation of persistent polar pollutants in wastewater: comparison of an optimized lab-scale membrane bioreactor and activated sludge treatment, Water Res, 40, 3419, 10.1016/j.watres.2006.07.011
Boillot C. Évaluation des risques écotoxicologiques liés aux rejets d'effluents hospitaliers dans les milieux aquatiques. Contribution à l'amélioration de la phase “caratérisation des effets”. PhD Thesis. Institut National des Sciences Appliquées de Lyon, France, N° d'ordre 2008 ISAL 0021.
Bottoni, 2010, Pharmaceuticals as priority water contaminants, Toxiol Environ Chem, 92, 549, 10.1080/02772241003614320
Brain, 2004, Effects of 25 pharmaceutical compounds to Lemna Gibba using a seven day static-renewal test, Environ Toxicol Chem, 23, 371, 10.1897/02-576
Brown, 2006, Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico, Sci Total Environ, 366, 772, 10.1016/j.scitotenv.2005.10.007
Carballa, 2004, Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant, Water Res, 38, 2918, 10.1016/j.watres.2004.03.029
Carballa, 2005, Behaviour of pharmaceuticals and personal care products in a sewage treatment plant of northwest Spain, Water Sci Technol, 52, 29, 10.2166/wst.2005.0218
Carucci, 2006, Biodegradability and toxicity of pharmaceuticals in biological wastewater treatment plants, J Environ Sci Heal A, 41, 1831, 10.1080/10934520600779000
Castiglioni, 2006, Removal of pharmaceuticals in sewage treatment plants in Italy, Environ Sci Technol, 40, 357, 10.1021/es050991m
Choi, 2008, Seasonal variation of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea, Sci Total Environ, 405, 120, 10.1016/j.scitotenv.2008.06.038
Cicek, 1999, Characterization and comparison of a membrane bioreactor and a conventional activated sludge system in the treatment of wastewater containing high-molecular weight compounds, Water Environ Res, 71, 64, 10.2175/106143099X121481
Cirja, 2008, Factors affecting the removal of organic micropollutants from wastewater in conventional treatment plants (CTP) and membrane bioreactors (MBR), Rev Environ Sci Biotechnol, 7, 61, 10.1007/s11157-007-9121-8
Clara, 2004, Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant, Water Sci Technol, 50, 29, 10.2166/wst.2004.0305
Clara, 2005, The solids retention time—a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants, Water Res, 39, 97, 10.1016/j.watres.2004.08.036
Clara, 2005, Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants, Water Res, 39, 4797, 10.1016/j.watres.2005.09.015
Cleuvers, 2003, Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects, Toxicol Lett, 142, 185, 10.1016/S0378-4274(03)00068-7
Cleuvers, 2004, Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid, Ecotox Environ Safe, 5, 309, 10.1016/S0147-6513(03)00141-6
Cleuvers, 2005, Initial risk assessment for three B_blockers found in the aquatic environment, Chemosphere, 59, 199, 10.1016/j.chemosphere.2004.11.090
Conti, 2011, Pharmaceuticals removal from urban wastewater by means of biological and physical–chemical treatments in full scale plants
Costanzo, 2005, Ecosystem response to antibiotics entering the aquatic environment, Mar Pollut Bull, 51, 218, 10.1016/j.marpolbul.2004.10.038
Coetsier, 2009, Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?, Environ Int, 35, 787, 10.1016/j.envint.2009.01.008
D'Ascenzo, 2003, Fate of natural estrogen conjugates in municipal sewage transport and treatment facilities, Sci Total Environ, 302, 199, 10.1016/S0048-9697(02)00342-X
Deblonde, 2011, Emerging pollutants in wastewater: a review of the literature, Int J hyg Envir Heal, 214, 442, 10.1016/j.ijheh.2011.08.002
De Souza, 2009, Environmental risk assessment of antibiotics: an intensive care unit analysis, Chemosphere, 77, 962, 10.1016/j.chemosphere.2009.08.010
Directive 2000/60/EC of October 23, 2000 of the European Parliament and of the Council establishing a framework for community action in the field of water policy O.J. L 327, December 22, 2000 (FWD).
Directice 2006/118/EC of December 12, 2006 of the European Parliament and of the Council on the protection of groundwater against pollution and deterioration.
Directive 2008/105/EC (PSD) of December 16, 2008 of the European Parliament and of the Council on environmental quality standards in the field of water policy, amending ad subsequently repealing Council Directives 82/176/EEC, 83/513/EEC, 84/156/EEC, 84/491/EEC, 86/280/EEC and amending Directive 2000/60/EC of European parliament and of the Council.
Escher, 2011, Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater, Water Res, 45, 75, 10.1016/j.watres.2010.08.019
European Community (EC), 2003
European Agency for the Evaluation of Medicinal Products (EMEA), 2001
Fatta-Kassinos, 2011, Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research, Anal Bioanal Chem, 399, 251, 10.1007/s00216-010-4300-9
Farré, 2001, Determination of drugs in surface water and wastewater samples by liquid chromatography–mass spectrometry: methods and preliminary results including toxicity studies with Vibro fisheri, J Chromatogr A, 938, 187, 10.1016/S0021-9673(01)01154-2
Ferrari, 2003, Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac, Ecotox Environ Safe, 55, 359, 10.1016/S0147-6513(02)00082-9
Ferrari, 2004, Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?, Environ Toxicol Chem, 23, 1344, 10.1897/03-246
Foster AL. Occurrence and fate of endocrine disruptors through the San Marco Wastewater treatment plant, Thesis of Master of Science, Texas State University. 2007.
Furhacker, 2008, The Water Framework Directive—can we reach the target?, Water Sci Technol, 57, 9, 10.2166/wst.2008.797
García-Galán, 2011, Occurrence of sulfonamide residues along the Ebro River basin. Removal in wastewater treatment plants and environmental impact assessment, Environ Int, 37, 462, 10.1016/j.envint.2010.11.011
Ghosh, 2009, Occurrence and elimination of antibiotics at four sewage treatment plants in Japan and their effects on bacterial ammonia oxidation, Water Sci Technol, 59, 779, 10.2166/wst.2009.067
Ginebreda, 2010, Environmental risk assessment of pharmaceuticals in rivers: relationship between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain), Environ Int, 36, 153, 10.1016/j.envint.2009.10.003
GWRC
Göbel, 2005, Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment, Environ Sci Technol, 39, 3981, 10.1021/es048550a
Göbel, 2007, Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies, Sci Total Environ, 372, 361, 10.1016/j.scitotenv.2006.07.039
Golet, 2003, Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil, Environ Sci Technol, 37, 3243, 10.1021/es0264448
Gómez, 2007, Pilot survey monitoring pharmaceuticals and related compounds in sewage treatment plant located on the Mediterranean cost, Chemosphere, 66, 993, 10.1016/j.chemosphere.2006.07.051
Goossens, 2007, Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries, Clinical Infectious Disease, 44, 1091, 10.1086/512810
Gros, 2010, Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes, Environ Int, 36, 15, 10.1016/j.envint.2009.09.002
Gulkowska, 2008, Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China, Water Res, 42, 395, 10.1016/j.watres.2007.07.031
Hai, 2011, Removal of micropollutants by membrane bioreactor under temperature variation, J Membrane Sci, 383, 144, 10.1016/j.memsci.2011.08.047
Halling-Sørensen, 1998, Occurrence, fate and effects of pharmaceuticals substances in the environment—a review, Chemosphere, 36, 357, 10.1016/S0045-6535(97)00354-8
Halling-Sørensen, 2000, Algal toxicity of antibacterial agents used in intensive farming, Chemosphere, 40, 731, 10.1016/S0045-6535(99)00445-2
Han, 2006, Ecotoxicological risk of pharmaceuticals from wastewater treatment plants in Korea: occurrence and toxicity to Daphnia magna, Environ Toxicol Chem, 25, 265, 10.1897/05-193R.1
Henschel, 1997, Environmental hazard assessment of pharmaceuticals, Regul Toxicol Pharm, 25, 220, 10.1006/rtph.1997.1102
Hernando, 2006, Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments, Talanta, 69, 334, 10.1016/j.talanta.2005.09.037
Huggett, 2002, Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (β-blockers) on aquatic organisms, Environ Contam Toxicol, 43, 229, 10.1007/s00244-002-1182-7
Jelic, 2011, Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment, Water Res, 45, 1165, 10.1016/j.watres.2010.11.010
Jia, 2012, Occurrence and fate of quinolone and fluoroquinolone antibiotics in a municipal sewage treatment plant, Water Res, 46, 387, 10.1016/j.watres.2011.10.055
Jones, 2002, Aquatic environmental assessment of the top 25 English prescription pharmaceuticals, Water Res, 36, 5013, 10.1016/S0043-1354(02)00227-0
Jones, 2005, Human pharmaceuticals in wastewater treatment processes, Crit Rev Env Sci Tec, 35, 401, 10.1080/10643380590956966
Jones, 2007, The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilizing activated sludge treatment, Environ Pollut, 145, 738, 10.1016/j.envpol.2005.08.077
Joss, 2004, Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization, Environ Sci Technol, 38, 3047, 10.1021/es0351488
Joss, 2005, Removal of pharmaceuticals and fragrances in biological wastewater treatment, Water Res, 39, 3139, 10.1016/j.watres.2005.05.031
Karthikeyan, 2006, Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA, Sci Total Environ, 361, 196, 10.1016/j.scitotenv.2005.06.030
Kasprzyk-Hordern, 2009, The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters, Water Res, 43, 363, 10.1016/j.watres.2008.10.047
Khan, 2005, Occurrence and removal of pharmaceuticals at an Australian sewage treatment plant, Water, 35
Kühn, 1989, Results of the harmful effects of water of water pollutants to Daphnia magna in the 21 day reproduction test, Water Res, 23, 501, 10.1016/0043-1354(89)90142-5
Kim, 2007, Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking and wastewaters, Water Res, 41, 1013, 10.1016/j.watres.2006.06.034
Kimura, 2005, Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs), Desalination, 178, 135, 10.1016/j.desal.2004.11.033
Kimura, 2007, Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors, Environ Sci Technol, 41, 3708, 10.1021/es061684z
Kreuzinger, 2004, Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceutical from wastewater, Water Sci Technol, 50, 149, 10.2166/wst.2004.0322
Kümmerer, 2003, Promoting resistance by the emission of antibiotics from hospitals and households into effluent, Clin Microbiol Infect, 9, 1203, 10.1111/j.1469-0691.2003.00739.x
Kümmerer, 1997, Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage, Water Res, 31, 2705, 10.1016/S0043-1354(97)00121-8
Kümmerer, 2009, Antibiotics in the aquatic environment—a review—part I, Chemosphere, 75, 417, 10.1016/j.chemosphere.2008.11.086
Kümmerer, 2009, The presence of pharmaceuticals in the environment due to human use—present knowledge and future challenges, J Environ Manage, 90, 2354, 10.1016/j.jenvman.2009.01.023
Lee, 2008, Risk assessment of human antibiotics in Korean aquatic environment, Environ Toxicol Phar, 26, 216, 10.1016/j.etap.2008.03.014
Lee, 2003, Sludge characteristics and their contribution to microfiltration in submerged membrane bioreactors, J Memb Sci, 216, 217, 10.1016/S0376-7388(03)00073-5
Le Minh, 2010, Fate of antibiotics during municipal water recycling treatment processes, Water Res, 44, 4295, 10.1016/j.watres.2010.06.020
Li, 2011, Mass flows and removal of antibiotics in two municipal wastewater treatment plants, Chemosphere, 83, 1284, 10.1016/j.chemosphere.2011.03.002
Liebig, 2006, Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products, Environ Sci Pollut R., 13, 110, 10.1065/espr2005.08.276
Lindberg, 2005, Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatments plants in Sweden, Environ Sci Technol, 39, 3421, 10.1021/es048143z
Lindberg, 2006, Behavior of Fluoroquinolones and Trimethoprime during mechanical, chemical, and active sludge treatment of sewage water and digestion of sludge, Environ Sci Technol, 40, 1042, 10.1021/es0516211
Lindqvist, 2005, Occurrence of acidic pharmaceuticals in raw and treated sewage and in receiving waters, Water Res, 39, 2219, 10.1016/j.watres.2005.04.003
Lishman, 2006, Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada, Sci Total Environ, 367, 544, 10.1016/j.scitotenv.2006.03.021
Marques, 2004, Life-history traits of standard and autochthonous cladocerans: II. Acute and chronic effects of acetylsalicylic acid metabolites, Environ Toxicol, 19, 527, 10.1002/tox.20060
Maurer, 2007, Elimination of β-blockers in sewage treatment plants, Water Res, 41, 1614, 10.1016/j.watres.2007.01.004
McAvoy, 2002, Measurement of triclosan in wastewater treatment systems, Environ Toxicol Chem, 21, 1323, 10.1002/etc.5620210701
Metcalfe, 2003, Occurrence of neutral and acidic drugs in the effluents of Canadian Sewage treatment plants, Environ Toxicol Chem, 22, 2872, 10.1897/02-469
Metcalfe, 2010, Antidepressants and their metabolites in municipal wastewater and downstream exposure in an urban watershed, Environ Technol Chem, 29, 79, 10.1002/etc.27
Miège, 2009, Fate of pharmaceuticals and personal care products in wastewater treatment plants—conception of a database and first results, Environ Pollut, 157, 1721, 10.1016/j.envpol.2008.11.045
Monteiro, 2010, Occurrence and fate of human pharmaceuticals in the environment, Rev Environ Contam T., 202, 53, 10.1007/978-1-4419-1157-5_2
Muñoz, 2009, Chemical evaluation of contaminants in wastewater effluents and the environmental risk of reusing effluents in agriculture, Trends Analyt Chem, 28, 676, 10.1016/j.trac.2009.03.007
Nakada, 2006, Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment, Water Res, 40, 3297, 10.1016/j.watres.2006.06.039
Onesios, 2009, Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review, Biodegradation, 20, 441, 10.1007/s10532-008-9237-8
Ort, 2006, Sampling for representative micropollutants loads in sewer systems, Water Sci Technol, 54, 169, 10.2166/wst.2006.591
Paxéus, 2004, Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, β-blockers, trimethoprime and triclosan in conventional wastewater treatment plants in EU countries and their discharge to the aquatic environment, Water Sci Technol, 50, 253, 10.2166/wst.2004.0335
Peng, 2006, A preliminary study on the occurrence and behavior of sulfonamides, ofloxacin and chloramphenicol antimicrobials in wastewater of two sewage treatment plants in Guangzhou, China, Sci Total Environ, 371, 314, 10.1016/j.scitotenv.2006.07.001
Perez, 2005, Evaluating the biodegradability of sulphametazine, sulfamethoxazole and trimethoprim at different stages of sewage treatment, Environ Toxicol Chem, 24, 1361, 10.1897/04-211R.1
Plósz, 2010, Impacts of competitive inhibition, parent compound formation and partitioning behaviour on antibiotic micro-pollutants removal in activated sludge, Environ Sci Technol, 44, 734, 10.1021/es902264w
Quinn, 2008, An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarians, Hydra attenuate, Sci Total Environ, 389, 306, 10.1016/j.scitotenv.2007.08.038
Quintana, 2005, Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor, Water Res, 39, 2654, 10.1016/j.watres.2005.04.068
Ra, 2008, The effect of suspended particles coated by humic acid on the toxicity of pharmaceuticals, estrogens, and phenolic compounds, Environ Int, 34, 184, 10.1016/j.envint.2007.08.001
Radjenovic, 2007, Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor, Anal Bioanal Chem, 387, 1365, 10.1007/s00216-006-0883-6
Radjenovic, 2009, Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor(MBR) treatment, Water Res, 43, 831, 10.1016/j.watres.2008.11.043
Reif, 2008, Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage, Desalination, 221, 511, 10.1016/j.desal.2007.01.111
Richardson, 2011, Water analysis: emerging contaminants and current issues, Anal Chem, 83, 4614, 10.1021/ac200915r
Rimkus, 1999, Polycyclic musk fragrances in aquatic environment, Toxicol Lett, 111, 37, 10.1016/S0378-4274(99)00191-5
Roberts, 2006, The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment, Sci Total Environ, 356, 143, 10.1016/j.scitotenv.2005.04.031
Rodriguez, 2003, Determination of acidic drugs in sewage water by gas chromatography–mass spectrometry as tert-butyldimethylsilyl derivatives, J Chromatogr A, 985, 265, 10.1016/S0021-9673(02)01528-5
Rosal, 2009, Identification of intermediates and assessment of ecotoxicity in the oxidation products generated during the ozonation of clofibric acid, J Hazard Mater, 172, 1061, 10.1016/j.jhazmat.2009.07.110
Rosal, 2010, Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation, Water Res, 44, 578, 10.1016/j.watres.2009.07.004
Ruel, 2010, On-site evaluation of the efficiency of conventional and advanced secondary processes for the removal of 60 organic micropollutants, Water Sci Technol, 62, 2970, 10.2166/wst.2010.989
Sahar, 2011, Comparison of two treatments for the removal of selected organic micropollutants and bulk organic matter: conventional activated sludge followed by ultrafiltration versus membrane bioreactor, Water Sci Technol, 63, 733, 10.2166/wst.2011.300
Salgot, 2006, Wastewater reuse and risk: definition of key objectives, Desalination, 187, 29, 10.1016/j.desal.2005.04.065
Sanderson, 2003, Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening, Toxicol Lett, 144, 83, 10.1016/S0378-4274(03)00257-1
Santos, 2007, Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain), Environ Int, 33, 596, 10.1016/j.envint.2006.09.014
Santos, 2009, Occurrence of pharmaceutically active compounds during 1-year period in wastewater from four wastewater treatment plants in Seville (Spain), J Hazard Mater, 164, 1509, 10.1016/j.jhazmat.2008.09.073
Schröder, 2002, Mass spectrometric monitoring of the degradation and elimination efficiency for hardly eliminable and hardly biodegradable polar compounds by membrane bioreactors, Water Sci Technol, 46, 57, 10.2166/wst.2002.0054
Sipma, 2010, Comparison of removal of pharmaceuticals in MBR and activated sludge systems, Desalination, 250, 653, 10.1016/j.desal.2009.06.073
Snyder, 2006, Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals, Desalination, 202, 156, 10.1016/j.desal.2005.12.052
Strenn, 2004, Carbamazepine, diclofenac, ibuprofen and bezafibrate—investigations on the behaviour of selected pharmaceuticals during wastewater treatment, Water Sci Technol, 50, 269, 10.2166/wst.2004.0337
Stuer-Lauridsen, 2000, Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use, Chemosphere, 40, 783, 10.1016/S0045-6535(99)00453-1
Stumpf, 1999, Polar drugs residues in sewage and natural waters in the state of Rio De Janeiro, Brazil, Sci Total Environ, 225, 135, 10.1016/S0048-9697(98)00339-8
Suárez, 2005, Removal of pharmaceutically active compounds in nitrifying–denitrifying plants, Water Sci Technol, 52, 9, 10.2166/wst.2005.0214
Suárez, 2008, How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters?, Rev Environ Sci Biotechnol, 7, 125, 10.1007/s11157-008-9130-2
Suárez, 2010, Removal of Pharmaceutical and Personal Care products(PPCPs) under nitrifying and denitrifying conditions, Water Res, 44, 3214, 10.1016/j.watres.2010.02.040
Tadkaew, 2010, Effect of mixed liquor pH on the removal of trace organic contaminants in a membrane bioreactor, Bioresource Technol, 101, 1494, 10.1016/j.biortech.2009.09.082
Tadkaew, 2011, Removal of trace organics by MBR treatment: the role of molecular properties, Water Res, 45, 2439, 10.1016/j.watres.2011.01.023
Tauxe-Wuersch, 2005, Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment, Water Res, 39, 1761, 10.1016/j.watres.2005.03.003
Ternes, 2007, Irrigation of treated wastewater in Braunschweig, Germany: an option to remove pharmaceuticals and musk fragrances, Chemosphere, 66, 894, 10.1016/j.chemosphere.2006.06.035
Ternes, 2004, A rapid method to measure the solid–water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge, Wat Res, 38, 4075, 10.1016/j.watres.2004.07.015
Ternes, 2006
Ternes, 2003, Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewaters?, Water Res, 37, 1976, 10.1016/S0043-1354(02)00570-5
Ternes, 1999, Behaviour and occurrence of estrogens in municipal sewage treatment plants—I. Investigations in Germany, Canada and Brazil, Sci Total Environ, 225, 81, 10.1016/S0048-9697(98)00334-9
Ternes, 1998, Occurrence of drugs in German sewage treatment plants and rivers, Water Res, 32, 3245, 10.1016/S0043-1354(98)00099-2
Thomas, 2005, Tracking acidic pharmaceutical, caffeine, and triclosan through the wastewater treatment process, Environ Technol Chem, 24, 25, 10.1897/04-144R.1
Van der Aa, 2011, Demographic projections of future pharmaceutical consumption in the Netherlands, Water Sci Technol, 63, 825, 10.2166/wst.2011.120
Tunkel, 2000, Predicting ready biodegradability in the Japanese ministry of international trade and industry test, Environ Toxicol Chem, 19, 2478, 10.1002/etc.5620191013
Urase, 2005, Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors, Desalination, 178, 107, 10.1016/j.desal.2004.11.031
US EPA, 1999. Search in Ecotoxicology Database System (U.S. EPA MED-Duluth) Available from: http://www.epa.gov/medecotx/ecotoxhome.htm.
US EPA, 2009. Nutrient Control Design Manual State of technology Review Report EPA/600/R-09/012 January 2009 Available from: http://www.epa.gov/nrmrl (last access March 27th 2012).
Vieno, 2005, Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water, Environ Sci Technol, 39, 8220, 10.1021/es051124k
Vieno, 2007, Elimination of pharmaceuticals in sewage treatment plants in Finland, Water Res, 41, 1001, 10.1016/j.watres.2006.12.017
Watkinson, 2007, Removal of antibiotics in conventional and advanced wastewater treatment: implications for environmental discharge and wastewater recycling, Water Res, 41, 4164, 10.1016/j.watres.2007.04.005
Weigel, 2004, Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites, Chemosphere, 56, 583, 10.1016/j.chemosphere.2004.04.015
Weiss, 2008, Membrane bioreactors for municipal wastewater treatment—a viable option to reduce the amount of polar pollutants discharged into surface waters?, Water Res, 42, 3837, 10.1016/j.watres.2008.05.019
Wick, 2009, Fate of beta blockers and psycho-active drugs in conventional wastewater treatment, Water Res, 43, 1060, 10.1016/j.watres.2008.11.031
Xu, 2007, Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl river delta (PRD), South China, Water Res, 41, 4526, 10.1016/j.watres.2007.06.023
Yasojima, 2006, Occurrence of levofloxacin, clarithromycin and azithromycin in wastewater treatment plant in Japan, Water Sci Technol, 53, 227, 10.2166/wst.2006.357
Yu, 2006, Occurrence and biodegradability studies of selected pharmaceuticals and personal care products in sewage effluent, Agr Water Manage, 86, 72, 10.1016/j.agwat.2006.06.015
Ziylan, 2011, The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: treatability by conventional and non conventional processes, J Hazard Mater, 187, 24, 10.1016/j.jhazmat.2011.01.057
Zorita, 2009, Occurrence and removal of pharmaceuticals in municipal sewage treatment system in the south of Sweden, Sci Total Environ, 407, 2760, 10.1016/j.scitotenv.2008.12.030